MYUNGMOON Pharm co.,Ltd (KRX:017180)
1,722.00
+17.00 (1.00%)
Last updated: Dec 5, 2025, 10:59 AM KST
MYUNGMOON Pharm co.,Ltd Revenue
MYUNGMOON Pharm co.,Ltd had revenue of 49.86B KRW in the quarter ending September 30, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to 193.64B, up 7.49% year-over-year. In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B with 9.95% growth.
Revenue (ttm)
193.64B
Revenue Growth
+7.49%
P/S Ratio
0.30
Revenue / Employee
665.44M
Employees
291
Market Cap
58.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 186.44B | 16.88B | 9.95% |
| Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
| Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
| Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
| Dec 31, 2020 | 127.85B | -21.49B | -14.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |